Exact Mass: 393.1801

Exact Mass Matches: 393.1801

Found 122 metabolites which its exact mass value is equals to given mass value 393.1801, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Latifoline

(+)-Latifoline

C20H27NO7 (393.1787)


   

Daprodustat

2-(1,3-Dicyclohexyl-6-hydroxy-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamido)acetic acid

C19H27N3O6 (393.19)


B - Blood and blood forming organs > B03 - Antianemic preparations C78275 - Agent Affecting Blood or Body Fluid Daprodustat (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor being developed for the treatment of anemia associated with chronic kidney disease.

   

1H-Indole-3-carboxylic acid, 1-methyl-, (1-(2-((methylsulfonyl)amino)ethyl)-4-piperidinyl)methyl ester

1H-Indole-3-carboxylic acid, 1-methyl-, (1-(2-((methylsulphonyl)amino)ethyl)-4-piperidinyl)methyl ester

C19H27N3O4S (393.1722)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists GR 113808 is a potent and highly selective 5-HT4?receptor antagonist (pKb= 8.8). GR 113808 shows 300-fold selectivity over 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2C and 5-HT3 receptors[1].

   

Pirenperone

3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one

C23H24FN3O2 (393.1852)


   

Acetylgynuramine

Gynuramine 19-O-acetate

C20H27NO7 (393.1787)


   

Pervilleine H

Pervilleine H

C20H27NO7 (393.1787)


   

Erythrozeylanine A

Erythrozeylanine A

C20H27NO7 (393.1787)


   

H-GLU-VAL-PHE-OH

Glutamyl-valyl-phenylalanine

C19H27N3O6 (393.19)


   

Pirenperone

Pirenperone

C23H24FN3O2 (393.1852)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Pirenperone (R 47465) is a 5-HT2 serotonin receptor antagonist. Pirenperone exhibits modest anxiolytic activity[1][2].

   

isoipanguline B

isoipanguline B

C20H27NO7 (393.1787)


   

jacobine-acetate

jacobine-acetate

C20H27NO7 (393.1787)


   
   

Phe Val Glu

Phe Val Glu

C19H27N3O6 (393.19)


   

Glu Phe Val

Glu Phe Val

C19H27N3O6 (393.19)


   

Phe Glu Val

Phe Glu Val

C19H27N3O6 (393.19)


   
   
   

Asp Ile Phe

Asp Ile Phe

C19H27N3O6 (393.19)


   
   
   

Val Phe Glu

Val Phe Glu

C19H27N3O6 (393.19)


   
   
   
   

Phe Asp Ile

Phe Asp Ile

C19H27N3O6 (393.19)


   

Ile Phe Asp

Ile Phe Asp

C19H27N3O6 (393.19)


   

Val Glu Phe

Val Glu Phe

C19H27N3O6 (393.19)


   

Ile Asp Phe

Ile Asp Phe

C19H27N3O6 (393.19)


   

Phe Ile Asp

Phe Ile Asp

C19H27N3O6 (393.19)


   

Glu-Val-Phe

Glu-Val-Phe

C19H27N3O6 (393.19)


   
   
   
   
   

Leu Asp Phe

Leu Asp Phe

C19H27N3O6 (393.19)


   
   
   

Asp Phe Ile

Asp Phe Ile

C19H27N3O6 (393.19)


   

Phe Leu Asp

Phe Leu Asp

C19H27N3O6 (393.19)


   

Phe Asp Leu

Phe Asp Leu

C19H27N3O6 (393.19)


   
   
   
   

Asp Leu Phe

Asp Leu Phe

C19H27N3O6 (393.19)


   
   

Leu Phe Asp

Leu Phe Asp

C19H27N3O6 (393.19)


   
   

Asp Phe Leu

Asp Phe Leu

C19H27N3O6 (393.19)


   

Glu Val Phe

Glu Val Phe

C19H27N3O6 (393.19)


   

ascr#8

N-(6R-[3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy]-2E-heptenoyl)-4-aminobenzoic acid

C20H27NO7 (393.1787)


A carboxamide resulting from the formal condensation of the carboxy group of ascr#7 with the amino group of 4-aminobenzoic acid. A metabolite of the nematode Caenorhabditis elegans, it is dauer inducing and strongly male attracting.

   

21-Amino-17-hydroxypregna-1,4-diene-3,11,20-trione hydrochloride

21-Amino-17-hydroxypregna-1,4-diene-3,11,20-trione hydrochloride

C21H28ClNO4 (393.1707)


   

N-HYDROXY-4-(4-METHYL-5-(2-(TRIFLUOROMETHYL)PHENYL)-4H-1,2,4-TRIAZOL-3-YL)BICYCLO[2.2.2]OCTANE-1-CARBOXIMIDAMIDE

N-HYDROXY-4-(4-METHYL-5-(2-(TRIFLUOROMETHYL)PHENYL)-4H-1,2,4-TRIAZOL-3-YL)BICYCLO[2.2.2]OCTANE-1-CARBOXIMIDAMIDE

C19H22F3N5O (393.1776)


   

Nalbuphine Hydrochloride

Nalbuphine Hydrochloride

C21H28ClNO4 (393.1707)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

2-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)isoindoline-1,3-dione

2-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)isoindoline-1,3-dione

C22H24BNO5 (393.1747)


   

(2S)-(+)-1-BENZOYL-2-TERT-BUTYL-3-METHYL-4-IMIDAZOLIDINONE

(2S)-(+)-1-BENZOYL-2-TERT-BUTYL-3-METHYL-4-IMIDAZOLIDINONE

C19H27N3O6 (393.19)


   

Rimcazole dihydrochloride

Rimcazole dihydrochloride

C21H29Cl2N3 (393.1738)


Rimcazole (BW 234U) dihydrochloride is a carbazole derivative that acts in part as a sigma (σ) receptor antagonist. Rimcazole dihydrochloride also binds with moderate affinity to the dopamine transporter and inhibit dopamine uptake. Rimcazole dihydrochloride can reduce locomotor activity and sensitization. Rimcazole dihydrochloride also can be used for the research of cancer[1][2][3][4].

   

N-Desmethyltamoxifen hydrochloride

N-Desmethyltamoxifen hydrochloride

C25H28ClNO (393.1859)


   

Fentanyl isothiocyanate

Fentanyl isothiocyanate

C23H27N3OS (393.1875)


   

4-({(2E,6R)-6-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hept-2-enoyl}amino)benzoic acid

4-({(2E,6R)-6-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hept-2-enoyl}amino)benzoic acid

C20H27NO7 (393.1787)


   

5-{[4-(9H-Fluoren-9-YL)piperazin-1-YL]carbonyl}-1H-indole

5-{[4-(9H-Fluoren-9-YL)piperazin-1-YL]carbonyl}-1H-indole

C26H23N3O (393.1841)


   

N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide

N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide

C26H23N3O (393.1841)


   

5-Fluoro-1-[4-(4-phenyl-3,6-dihydropyridin-1(2H)-YL)butyl]quinazoline-2,4(1H,3H)-dione

5-Fluoro-1-[4-(4-phenyl-3,6-dihydropyridin-1(2H)-YL)butyl]quinazoline-2,4(1H,3H)-dione

C23H24FN3O2 (393.1852)


   

Daprodustat

Daprodustat

C19H27N3O6 (393.19)


B - Blood and blood forming organs > B03 - Antianemic preparations C78275 - Agent Affecting Blood or Body Fluid Daprodustat (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor being developed for the treatment of anemia associated with chronic kidney disease.

   

Glutamylvalylphenylalanine

Glutamylvalylphenylalanine

C19H27N3O6 (393.19)


   

2-[[(3R)-3-(4-fluorophenyl)-3-(4-phenylphenoxy)propyl]-methylamino]acetic acid

2-[[(3R)-3-(4-fluorophenyl)-3-(4-phenylphenoxy)propyl]-methylamino]acetic acid

C24H24FNO3 (393.174)


   

Leu-Phe-Asp

Leu-Phe-Asp

C19H27N3O6 (393.19)


A tripeptide composed of L-leucine, L-phenylalanine and L-aspartic acid joined in sequence by peptide linkages.

   

Asp-Leu-Phe

Asp-Leu-Phe

C19H27N3O6 (393.19)


   

[1-[2-(2-Methylphenoxy)ethyl]-3-indolyl]-(4-methyl-1-piperazinyl)methanethione

[1-[2-(2-Methylphenoxy)ethyl]-3-indolyl]-(4-methyl-1-piperazinyl)methanethione

C23H27N3OS (393.1875)


   

11-(3-methoxypropyl)-3-((tetrahydrofuran-2-yl)methyl)-3H-pyrimido[5,4:4,5]pyrrolo[2,3-b]quinoxalin-4(11H)-one

11-(3-methoxypropyl)-3-((tetrahydrofuran-2-yl)methyl)-3H-pyrimido[5,4:4,5]pyrrolo[2,3-b]quinoxalin-4(11H)-one

C21H23N5O3 (393.1801)


   

Glu-Phe-Val

Glu-Phe-Val

C19H27N3O6 (393.19)


A tripeptide composed of L-glutamic acid, L-phenylalanine and L-valine joined in sequence by peptide linkages.

   
   
   
   

Val-Glu-Phe

Val-Glu-Phe

C19H27N3O6 (393.19)


   

Asp-Ile-Phe

Asp-Ile-Phe

C19H27N3O6 (393.19)


   
   
   

Nalbufina clorhidrato

Nalbufina clorhidrato

C21H28ClNO4 (393.1707)


   

(3E)-1-[3-(dimethylamino)propyl]-5-fluoro-3-[(5-methoxy-1H-indol-3-yl)methylidene]indol-2-one

(3E)-1-[3-(dimethylamino)propyl]-5-fluoro-3-[(5-methoxy-1H-indol-3-yl)methylidene]indol-2-one

C23H24FN3O2 (393.1852)


   

4-[4-[(1S,5R)-3-(1-oxo-2-phenylethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

4-[4-[(1S,5R)-3-(1-oxo-2-phenylethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C26H23N3O (393.1841)


   

[(1S)-1-ethylsulfonyl-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

[(1S)-1-ethylsulfonyl-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C19H27N3O4S (393.1722)


   

[(1R)-1-ethylsulfonyl-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol

[(1R)-1-ethylsulfonyl-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C19H27N3O4S (393.1722)


   

[(1R)-1-ethylsulfonyl-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

[(1R)-1-ethylsulfonyl-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C19H27N3O4S (393.1722)


   

Phe-Asp-Leu

Phe-Asp-Leu

C19H27N3O6 (393.19)


   
   

Phe-Ile-Asp

Phe-Ile-Asp

C19H27N3O6 (393.19)


   
   
   
   

Asp-Phe-Ile

Asp-Phe-Ile

C19H27N3O6 (393.19)


   

Asp-Phe-Leu

Asp-Phe-Leu

C19H27N3O6 (393.19)


   

Ile-Asp-Phe

Ile-Asp-Phe

C19H27N3O6 (393.19)


   
   

Ile-Phe-Asp

Ile-Phe-Asp

C19H27N3O6 (393.19)


   

Leu-Asp-Phe

Leu-Asp-Phe

C19H27N3O6 (393.19)


   
   
   
   

Phe-Asp-Ile

Phe-Asp-Ile

C19H27N3O6 (393.19)


   

Phe-Glu-Val

Phe-Glu-Val

C19H27N3O6 (393.19)


   

Phe-Leu-Asp

Phe-Leu-Asp

C19H27N3O6 (393.19)


   
   

Phe-Val-Glu

Phe-Val-Glu

C19H27N3O6 (393.19)


   
   

Val-Phe-Glu

Val-Phe-Glu

C19H27N3O6 (393.19)


   

GR113808

1H-Indole-3-carboxylic acid, 1-methyl-, (1-(2-((methylsulfonyl)amino)ethyl)-4-piperidinyl)methyl ester

C19H27N3O4S (393.1722)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists GR 113808 is a potent and highly selective 5-HT4?receptor antagonist (pKb= 8.8). GR 113808 shows 300-fold selectivity over 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2C and 5-HT3 receptors[1].

   

ST 18:3;O5;Gly

ST 18:3;O5;Gly

C20H27NO7 (393.1787)


   

{7-[(2-methylbut-2-enoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl}methyl 3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

{7-[(2-methylbut-2-enoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl}methyl 3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

C20H27NO7 (393.1787)


   

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}butanedioic acid

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}butanedioic acid

C19H27N3O6 (393.19)


   

(1r,7r,7ar)-7-({[(2r,3r)-2,3-dihydroxy-2-methylbutanoyl]oxy}methyl)-hexahydro-1h-pyrrolizin-1-yl 2-hydroxybenzoate

(1r,7r,7ar)-7-({[(2r,3r)-2,3-dihydroxy-2-methylbutanoyl]oxy}methyl)-hexahydro-1h-pyrrolizin-1-yl 2-hydroxybenzoate

C20H27NO7 (393.1787)


   

[(7r)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4r)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

[(7r)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4r)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

C20H27NO7 (393.1787)


   

[(7s,7ar)-7-{[(2e)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r,3r,4s)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

[(7s,7ar)-7-{[(2e)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r,3r,4s)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

C20H27NO7 (393.1787)


   

[(7r)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r,3s,4s)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

[(7r)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r,3s,4s)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

C20H27NO7 (393.1787)


   

(1r,3s,5s,6s,7s)-6,7-dihydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate

(1r,3s,5s,6s,7s)-6,7-dihydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate

C20H27NO7 (393.1787)


   

(1r,3r,5s,6r)-6-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3,4,5-trimethoxybenzoate

(1r,3r,5s,6r)-6-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3,4,5-trimethoxybenzoate

C20H27NO7 (393.1787)


   

{4-ethylidene-7-hydroxy-7-methyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-6-yl}methyl acetate

{4-ethylidene-7-hydroxy-7-methyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-6-yl}methyl acetate

C20H27NO7 (393.1787)


   

[(7r,7ar)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4r)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

[(7r,7ar)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4r)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

C20H27NO7 (393.1787)


   

(1r,7r,7ar)-7-({[(2s,3r)-2,3-dihydroxy-2-methylbutanoyl]oxy}methyl)-hexahydro-1h-pyrrolizin-1-yl 2-hydroxybenzoate

(1r,7r,7ar)-7-({[(2s,3r)-2,3-dihydroxy-2-methylbutanoyl]oxy}methyl)-hexahydro-1h-pyrrolizin-1-yl 2-hydroxybenzoate

C20H27NO7 (393.1787)


   

[(1r,4z,6s,7s,17s)-4-ethylidene-7-hydroxy-7-methyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-6-yl]methyl acetate

[(1r,4z,6s,7s,17s)-4-ethylidene-7-hydroxy-7-methyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-6-yl]methyl acetate

C20H27NO7 (393.1787)


   

[(7r,7ar)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4s)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

[(7r,7ar)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s,3r,4s)-3-hydroxy-2,4-dimethyl-5-oxooxolane-3-carboxylate

C20H27NO7 (393.1787)


   

[(1r,4e,6s,7s,17s)-4-ethylidene-7-hydroxy-7-methyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-6-yl]methyl acetate

[(1r,4e,6s,7s,17s)-4-ethylidene-7-hydroxy-7-methyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-6-yl]methyl acetate

C20H27NO7 (393.1787)


   

7-{[(2,3-dihydroxy-2-methylbutanoyl)oxy]methyl}-hexahydro-1h-pyrrolizin-1-yl 2-hydroxybenzoate

7-{[(2,3-dihydroxy-2-methylbutanoyl)oxy]methyl}-hexahydro-1h-pyrrolizin-1-yl 2-hydroxybenzoate

C20H27NO7 (393.1787)